A Pittsburgh-based pharmaceutical company has acquired Hanover-based pain medicine manufacturer, Fathom Pharma. 

The Pennsylvania Department of Drug and Alcohol Programs is accepting grant applications from organizations offering employment or recovery support services to people with opioid use disorder.

Ephrata-based Retreat Behavioral Health will open a mental health and substance abuse treatment center in Connecticut next week.

Pennsylvania’s physicians are writing fewer opioid prescriptions while increasing their usage of the state’s prescription drug monitoring program, according to the 2019 Opioid Progress Report.

Pennsylvania’s top attorney is defending his efforts to make drug-maker Purdue Pharma pay for the way it marketed the painkiller OxyContin to doctors in Pennsylvania.

From an employer's perspective, long-term opioid use will likely equate to a high exposure claims with costly medical expenses, sometimes totaling thousands per month.